Digital Commons Network^™

Oncolog, Volume 47, Number 11, November 2002, Mariann Crapanzano, Kerry L. Wright, Frank A. Morello Jr. Md

OncoLog MD Anderson's Report to Physicians (All issues)

• Diagnosis Based on Nonsurgical Biopsy: A Cooperative Effort
• Benign Care: Young Patients with a Variety of Noncancerous Conditions Find Treatment at M.D. Anderson Cancer Center
• Cognitive Interventions Are Crucial for Many Patients with Neurofibromatosis
• FNA Clinic Streamlines Biopsy Diagnosis of Palpable Lesions
• "Is This Going to Hurt?", by Frank A. Morello Jr., MD, Assistant Professor, Section of Vascular and Interventional Radiology
• House Call: Answers to Common Questions about the Use of Radioisotopes for Diagnosis

Oncolog, Volume 47, Number 09, September 2002, Kerry L. Wright, Dawn Chalaire, Karyn Hede, Martin L. Smith Std, Anne J. Flamm Jd

OncoLog MD Anderson's Report to Physicians (All issues)

• Is Hormone Replacement Therapy an Option for Women with a History of Breast Cancer?
• Breast Cancer Survivor Devotes Life to Helping Those at High Risk for Hereditary Cancers
• "I Have Something to Tell You." Counselors Support Family Communication about Genetic Susceptibility to Cancer
• DiaLog: Bigger than a Blood Test: Ethical Cautions about Genetic Testing, by Martin L. Smith, STD, and Anne J. Flamm, JD
• House Call: Just a Phase: Understanding Clinical Trials
• Discovery Sheds Light on How Breast Cancer Cells Progress to More Aggressive Forms

Oncolog, Volume 47, Number 06, June 2002, Kate O'Suilleabhain, Dawn Chalaire, Shellie M. Scott Bs

OncoLog MD Anderson's Report to Physicians (All issues)

• Drug Development Program Paves the Way for FDA Approval of New Agents
• Pediatric New Agents Working Group Advances the Study of Novel Treatments in Young Patients
• DiaLog: Patients and Physicians: Partners in Health Care, by Shellie M. Scott, BS, Physician Assistant, Department of Urology
• House Call: Taking a More Active Role in Your Own Health Care
• As Population of Cancer Survivors Grows, Studies of Long-Term Health Effects Become More Critical, Researchers Say

Circulating Testosterone And Prostate-Specific Antigen In Nipple Aspirate Fluid And Tissue Are Associated With Breast Cancer., Edward R Sauter, David S Tichansky, Inna Chervoneva, Eleftherios P Diamandis

Department of Surgery Faculty Papers

Preliminary evidence has associated testosterone and prostate-specific antigen (PSA) with breast cancer. Our objective was to determine whether a) testosterone levels in nipple aspirate fluid (NAF), serum, or breast tissue are associated with breast cancer; b) testosterone levels in serum are associated with levels in NAF; c) PSA in NAF, serum, or breast tissue is associated with breast cancer; and d) serum PSA is associated with NAF PSA levels. We obtained 342 NAF specimens from 171 women by means of a modified breast pump. Additionally, we collected 201 blood samples from 99 women and 51 tissue samples from 41 subjects …

Oncolog, Volume 47, Number 03, March 2002, Vickie J. Williams, Michael Worley, Noelle Heinze, Richard J. Babaian Md

OncoLog MD Anderson's Report to Physicians (All issues)

• Largest-Ever Cancer Prevention Study to Examine the Effects of Selenium and Vitamin E on Prostate Cancer Occurrence
• Protocols: Prostate Cancer Clinical Trials
• House Call: Understanding Metastasis
• DiaLog: The Prostate--Specific Antigen Test: Reliability and Recommended Use, by Richard J. Babaian, MD, Professor, Department of Urology
• Trouble Spots: Early Detection Is Key to the Successful Treatment of Melanoma